Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES vs AUROBINDO PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DIVIS LABORATORIES AUROBINDO PHARMA DIVIS LABORATORIES/
AUROBINDO PHARMA
 
P/E (TTM) x 31.9 14.3 222.7% View Chart
P/BV x 8.4 1.4 597.8% View Chart
Dividend Yield % 0.8 1.5 52.9%  

Financials

 DIVIS LABORATORIES   AUROBINDO PHARMA
EQUITY SHARE DATA
    DIVIS LABORATORIES
Mar-22
AUROBINDO PHARMA
Mar-22
DIVIS LABORATORIES/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs5,4251,064 510.0%   
Low Rs3,562584 609.7%   
Sales per share (Unadj.) Rs337.5400.3 84.3%  
Earnings per share (Unadj.) Rs111.545.7 244.0%  
Cash flow per share (Unadj.) Rs123.364.9 189.8%  
Dividends per share (Unadj.) Rs30.009.00 333.3%  
Avg Dividend yield %0.71.1 61.1%  
Book value per share (Unadj.) Rs441.8419.4 105.3%  
Shares outstanding (eoy) m265.47585.94 45.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x13.32.1 646.8%   
Avg P/E ratio x40.318.0 223.5%  
P/CF ratio (eoy) x36.512.7 287.3%  
Price / Book Value ratio x10.22.0 517.7%  
Dividend payout %26.919.7 136.6%   
Avg Mkt Cap Rs m1,192,890482,799 247.1%   
No. of employees `000NANA-   
Total wages/salary Rs m9,46234,509 27.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m89,598234,555 38.2%  
Other income Rs m1,1593,226 35.9%   
Total revenues Rs m90,757237,781 38.2%   
Gross profit Rs m38,81142,566 91.2%  
Depreciation Rs m3,11511,265 27.7%   
Interest Rs m20486 4.1%   
Profit before tax Rs m36,83534,040 108.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7,2317,256 99.6%   
Profit after tax Rs m29,60526,784 110.5%  
Gross profit margin %43.318.1 238.7%  
Effective tax rate %19.621.3 92.1%   
Net profit margin %33.011.4 289.4%  
BALANCE SHEET DATA
Current assets Rs m96,104181,227 53.0%   
Current liabilities Rs m24,54481,560 30.1%   
Net working cap to sales %79.942.5 188.0%  
Current ratio x3.92.2 176.2%  
Inventory Days Days925 34.8%  
Debtors Days Days98762 1,581.5%  
Net fixed assets Rs m50,087155,104 32.3%   
Share capital Rs m531586 90.6%   
"Free" reserves Rs m116,751245,174 47.6%   
Net worth Rs m117,282245,760 47.7%   
Long term debt Rs m02,492 0.0%   
Total assets Rs m146,191336,331 43.5%  
Interest coverage x1,842.871.0 2,596.0%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.60.7 87.9%   
Return on assets %20.38.1 249.9%  
Return on equity %25.210.9 231.6%  
Return on capital %31.413.9 225.9%  
Exports to sales %031.1 0.0%   
Imports to sales %19.711.9 165.5%   
Exports (fob) Rs mNA72,862 0.0%   
Imports (cif) Rs m17,67627,965 63.2%   
Fx inflow Rs m78,44577,245 101.6%   
Fx outflow Rs m17,95331,524 57.0%   
Net fx Rs m60,49245,721 132.3%   
CASH FLOW
From Operations Rs m19,11850,165 38.1%  
From Investments Rs m-21,949-32,116 68.3%  
From Financial Activity Rs m-5,324-29,693 17.9%  
Net Cashflow Rs m-8,156-11,674 69.9%  

Share Holding

Indian Promoters % 51.9 48.8 106.5%  
Foreign collaborators % 0.0 3.1 -  
Indian inst/Mut Fund % 36.5 38.0 96.1%  
FIIs % 16.5 20.7 79.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.1 48.2 99.8%  
Shareholders   346,905 359,684 96.4%  
Pledged promoter(s) holding % 0.0 15.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DIVIS LABORATORIES With:   SUN PHARMA    DR. REDDYS LAB    LUPIN    CIPLA    ZYDUS LIFESCIENCES    



Today's Market

Sensex Zooms 130 Points, Nifty Ends Above 17,600; Financial and IT Stocks Rally(Closing)

Indian benchmark indices ended on a positive note amid a highly volatile session. This was on the back of metal stocks along with banking and financials.